Drug Safety, or Overregulation of Reproductive Health?
Scholar calls for FDA to remove stringent restrictions on medication abortion.
Telehealth Abortion Care
Scholars consider how the authorization of telehealth can expand access to medication abortion.
Week in Review
President Biden announces nominee to head OIRA, a federal judge blocks coverage of HIV prevention drugs, and more…
Digital Privacy in the Post-Dobbs Landscape
Following the Supreme Court’s decision overturning Roe v. Wade, experts discuss abortion-related data privacy concerns.
Constitutional Commitments to Aspirational Principles
The majority’s reasoning in Dobbs v. Jackson Women’s Health entrenches the historical failures of the United States.
The Supreme Court’s 2021-2022 Regulatory Term
Scholars and practitioners discuss the Court’s most significant regulatory decisions of the last term.
Aborting the Right to Abortion
A leaked draft of a Supreme Court opinion turns the national debate over Roe v. Wade on its head.
Protecting Abortion Post-Roe
Scholars offer suggestions for protecting abortion rights if the Supreme Court overturns Roe v. Wade.
Crisis Pregnancy Centers, State-Funded Harm, and State-Based Solutions
As the Supreme Court evaluates abortion laws, states should bolster reproductive rights and better regulate CPCs.
Reversing Roe in Texas
Under the state’s recently enacted restrictions, experts say access to abortion has been effectively gutted.
The Future of the Abortion Pill
FDA’s regulation of medication abortion must be guided by science, not politics.
Impacts of Targeted Regulation of Abortion Providers
Regulations targeting abortion clinics significantly impact abortion access and public health.